To The Moon

$Palantir Technologies Inc.(PLTR)$ Despite Palantir’s relatively high valuation, Truist Securities initiated coverage with a Buy rating and a $223 price target, citing the company’s massive opportunity in driving general AI adoption across government and enterprise clients. Palantir’s position as an analytics- and data-driven software leader gives it long-term upside. Just follow the trade and buy along.

$IDT INT'L(00167)$ thesis playing out nicely! Their IoT biz like smart meters is gaining real traction. Holding with confidence~ Major FOMO for missing Contra688 - those vouchers are a game-changer. Next promo I'm not hesitating!

$Butong Group(06090)$ The parenting "super-influencer" from Xiaohongshu exploded onto the HKEX! It skyrocketed 44% on its first day, becoming the market's darling. The IPO saw a crazy level of oversubscription from retail investors, raising nearly $100M. I'm bullish on this hot trend!

$Alphabet(GOOG)$ 's AI & cloud combo firing! Gemini boosting ads + cloud gaining share. Tech giant's moat getting deeper - steady gains ahead!

$BABA-W(09988)$ finally showing strength! China tech rebound & e-commerce recovery working together. Patience pays off - may all your holdings glow green!

$JIHONG CO(02603)$ What a pleasant surprise! My JIHONG CO position has achieved an unrealized gain of 28,430.46 HKD! With the price rising from my entry at 10,035 to the current 12,620, that's over 25% return! This success reaffirms my stock selection strategy - patience and value investing always pay off in the long run. Holding strong for greater returns ahead!

$Zai Lab Ltd(ZLAB)$ I’ve been keeping an eye on Zai Lab for a while, and their ZL-1310 just stole the spotlight at ASCO! A bunch of Wall Street analysts are saying the data was way above expectations. Morgan Stanley even dropped a fresh report, and management shared more insights during the earnings call. Compared to its competitor Tarlatamab, ZL-1310 has a differentiated MoA and easier administration，if the data keeps looking good, its edge will only grow stronger. Plus, the FDA didn’t object to its accelerated path as a monotherapy for 2L SCLC. A pivotal study is expected to kick off in the second half of 2025, with OS and ORR as primary endpoints. If that trial launches as planned, it’ll be a key catalyst for the stock. And don’t forget，by year

$e.l.f. Beauty Inc.(ELF)$ With the US-China tariff reduction deal, it’s a huge win for consumer stocks like e.l.f. Beauty. potential for a sales boost! This is definitely an acceleration play, don’t miss the ride!

$ProShares UltraPro Dow30(UDOW)$ The overall US stock market is volatile. In this situation, we need to keep a close eye on market changes and make money from fluctuations.

$TENCENT(00700)$ is about to unveil its highly anticipated fourth-quarter 2024 results on Wednesday—and the excitement is palpable! Multiple analysts are forecasting a jaw-dropping 64.5% year-on-year surge in net profit to 44.46 billion yuan (around 6.15 billion USD), signaling that Tencent is roaring back to growth at an incredible pace. Even more thrilling, adjusted net income is expected to rise by a solid 25%, reaching 53.38 billion yuan! With strong gaming and advertising revenue, fourth-quarter revenue is projected to grow by 9.0%, hitting 169.15 billion yuan. Tencent is marching confidently toward an even brighter future, continuing to deliver amazing surprises for us. With such a powerful earnings report just around the corner, who can do